NCT01660022 - Safety Tolerability & Pharmacokinetics of Co-administered Single Doses of OZ439 & Piperaquine to Healthy Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions

Healthy

Interventions

DRUG

100mg OZ439 single oral dose

100mg OZ439 oral suspension single dose

DRUG

Placebo

DRUG

300 mg OZ439 single oral dose

300mg OZ439 oral suspension single dose

DRUG

160mg Piperaquine single oral dose

160 mg Piperaquine tablet

DRUG

480mg Piperaquine single oral dose

480 mg Piperaquine tablet

DRUG

1440mg Piperaquine single oral dose

1440 mg Piperaquine tablet

DRUG

800 mg OZ439 single oral dose

800mg OZ439 oral suspension single dose

Trial Locations (1)

Cross Research S.A., Mendrisio